Sunday, November 8, 2026
25.7 C
Bengaluru

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

Anuj Pasrija has been elevated to Country Lead, Johnson & Johnson MedTech India, and Vice President – Surgery, taking on an expanded leadership mandate focused on business growth, commercial execution, and surgical innovation in India.

With over 30 years of global business leadership experience, Pasrija brings expertise in P&L management, commercial strategy, market expansion, and leading complex, multinational organizations. His career spans North America, Asia-Pacific, and Africa, where he has led large teams and scaled businesses across diverse healthcare markets.

Prior to this elevation, Pasrija served as Vice President – Strategic Customer Group at Johnson & Johnson MedTech in Canada. In that role, he managed a substantial business portfolio, working with major healthcare systems and procurement organizations to strengthen commercial performance, develop strategic partnerships, and support the adoption of advanced surgical technologies.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Topics

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img